Founded: 2017
pi Investment: 2017
Founders: Geetha Manjunath
Website: www.niramai.com
Breast Cancer is the leading cause of cancer in women. It is well-established that early diagnosis is very critical in saving a life of a cancer patient. Co-founded by Geetha Manjunath and Nidhi Mathur, researchers at NIRAMAI have developed a new cancer screening software that uses machine intelligence over thermography images to enable a low cost, easy to use, portable solution and requires minimal human supervision. NIRAMAI solution uses a high resolution thermal sensing device and cloud hosted analytics solution for analysing the thermal images. The SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in the solution have led to multiple US patents.
15
Companies Funded
$30M (INR 225Cr)
Fund Corpus
Seed, Pre-Series A, Series A
Stage Focus
$500K - $2M
Ticket Size
Our core team brings decades of operating experience in building disruptive technology companies, business strategy, and global investments. While we bring diverse perspectives, we are bound by a shared passion for backing bold entrepreneurs in DeepTech. We believe in conviction-led investing and supporting our founders throughout their journey.
Strong participation from existing and new LPs
Fund II will look at companies focused on disruptive AI and other forms of Deep Tech across sectors including but not limited to Blockchain, Spacetech, Biotech, Material Science, etc. Through a corpus that is 3x as large as Fund I, we will aim to go deeper in portfolio winners in subsequent rounds.
AI for Marketing Automation
Pixis is a no code AI platform for fully automated creative generation and targeted marketing campaigns to achieve significant marketing RoI for its customers currently across India, NA, and EU.
AI for Antibody Discovery & Screening
immunitoAI is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.
Ai Palette predicts trends for F&B companies
Ai Palette's Foresight Engine uses sophisticated NLP models and image recognition trained on F&B datasets to deliver significant product innovation time and cost savings for clients.
© 2021